The RD4 immunoreactivity of AD tau (composed of 3R and 4R tau) is different from that of CBD tau and PSP tau (composed of 4R tau), suggesting that the tau filament core structures may be different. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.